Naina Sawal
Papers
1
Total Citations
8
H-Index
1
About
Naina Sawal is a rising clinical researcher whose work is shaping the future of precision diagnostics in thoracic oncology. Her primary focus lies at the intersection of advanced interventional pulmonology and molecular pathology, particularly in the context of lung cancer. Her most-cited paper, "Efficacy of Robotic Bronchoscopy for Molecular Marker Analysis in Primary Lung Cancer" (2023), has already garnered 8 citations, demonstrating early impact in a rapidly evolving field. In this work, Sawal critically evaluates the ability of robotic-assisted bronchoscopy to obtain high-quality tissue samples sufficient for comprehensive genomic profiling—a crucial step for guiding targeted therapies and immunotherapies. By validating the technique’s diagnostic yield and safety, she provides compelling evidence that robotic platforms can overcome traditional sampling limitations, potentially reducing the need for more invasive procedures. This contribution is especially significant as it directly addresses a clinical bottleneck in personalized lung cancer care. Sawal’s research is notable for its translational relevance, bridging cutting-edge technology with tangible patient benefit. Her work positions her as a key voice in the ongoing effort to make minimally invasive, molecularly guided treatment a standard of care for lung cancer patients.
Research Focus
Key Achievements
Top Papers
- 1